Percentage of Risk Management Plan review for new drug decisions completed within service standard (English, French, CSV)

Percentage of Risk Management Plan review for new drug decisions completed within service standard: English/French CSV file (13 KB) you can open as a table, filter, chart and export up to 10,000 rows. From Health Canada, updated Jul 2025.

Format
CSV
Access
Table on demand (prepared when opened)
Size
13,502 bytes
Publisher-reported update
2025-07-10

Risk Management Plan reviews protect Canadians from preventable hazards, and contribute to effective engagement with partners and stakeholders - in view of the department's reliance on shared responsibilities. This indicator measures post-market effectiveness in providing Canadians with access to safe, effective and quality health products in a timely manner. Risk Management Plan reviews are an important component of improving the health and safety of Canadians.

Access original file

Data overview

Formats
CSV
File languages
English, French
Available actions
Explore table (prepared automatically) · Access original file

Sample rows

The first 10 rows, as CanQuery read them from the start of the publisher's file on 2026-11-10. Showing 20 of 23 columns.

Lead_BureauBureau_principaleProduct_LineType_de_produitDSTS_NoSAP_NoProduct_Name-Nom_du_produitActive_Ingred-Ingredient_actifReview_TypeType_dexamenDate_ReceivedDate_de_receptionDate_AssignedDate_assigneeDate_FinishDate_de_finMissed_Greater_7Missed_Within_7Completed_Target-Cible_termineeFiscal_Year-Année_fiscale
MBBNHPBBPBBSNCBiologicBiologique2123873010678BIOTHRAXANTHRAX VACCINE ADSORBEDRMP NDSPGR PDN16-Feb-201816 févr. 201808-May-20188 mai 201816-Sep-201816 sept. 20180012018
MBBNHPBBPBBSNCBiologicBiologique2115413010633KAMRABANTI-RABIES IMMUNOGLOBIN (HUMAN)RMP NDSPGR PDN12-Jan-201812 janv. 201827-Feb-201827 févr. 201804-Jun-20184 juin 20180012018
MBBNHPBBPBBSNCBiologicBiologique2109353010673JIVIANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATEDRMP NDSPGR PDN08-Jan-20188 janv. 201813-Mar-201813 mars 201805-Jul-20185 juil. 20180012018
MBBNHPBBPBBSNCBiologicBiologique2083643010585DWP-40BOTULINUM TOXIN TYPE ARMP NDSPGR PDN20-Oct-201720 oct. 201730-Jan-201830 janv. 201829-May-201829 mai 20180012018
MBBNHPBBPBBSNCBiologicBiologique2133033010803VYNCROCANAKINUMABRMP NDSPGR PDN25-Sep-201825 sept. 201820-Jan-201920 janv. 20190012018
MBBNHPBBPBBSNCBiologicBiologique2120663010657UNITUXINDINUTUXIMABRMP NDSPGR PDN01-Feb-20181 févr. 201809-May-20189 mai 201816-Sep-201816 sept. 20180012018
MBBNHPBBPBBSNCBiologicBiologique2140803010766NIVESTYM (BIOSIMILAR TO NEUPOGEN)FILGRASTIMRMP NDSPGR PDN16-Apr-201816 avr. 201813-Jun-201813 juin 201816-Oct-201816 oct. 20180012018
MBBNHPBBPBBSNCBiologicBiologique2120163010677ZARXIO (BIOSIMILAR TO NEUPOGEN)FILGRASTIMRMP NDSPGR PDN05-Feb-20185 févr. 201808-May-20188 mai 201817-Sep-201817 sept. 20180102018
MBBNHPBBPBBSNCBiologicBiologique207,702,208,107,208,0003010516TRUMIXARITUXIMABRMP NDSPGR PDN08-Sep-20178 sept. 201728-Nov-201728 nov. 201712-Apr-201812 avr. 20180102018
MBBNHPBBPBBSNCBiologicBiologique2140583010742RIXATHONRITUXIMABRMP NDSPGR PDN20-Apr-201820 avr. 201819-Jul-201819 juil. 201819-Nov-201819 nov. 20180012018

Official sources and licences

Related open data